Innovations in Obesity Treatment: Beyond Adipose Tissue Dysfunction
Obesity Reviews · 2026-12 · 27 (12)
DOI: 10.1111/obr.70164 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Obesity Reviews, online erschienen am 17.05.2026. Verfasst von Jesica Martínez-Godfrey und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación en Biotecnología y Salud (IDiBE), Universidad Miguel Hernández de Elche (UMH), Elche, Spain. Hauptthemen laut MEDLINE: Obesity, Adipose Tissue. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Spanish Ministry of Economy and Competitiveness, Generalitat Valenciana, Spanish Ministry of Science, Innovation and Universities.
Abstract (Originalsprache)
Obesity, a chronic disease characterized by excessive adipose tissue accumulation, represents a critical global health challenge with profound metabolic, inflammatory, and oncogenic implications. To provide a multidisciplinary perspective, this narrative review integrates current literature examining metabolic, immunological, and oncological evidence to outline obesity as a multisystem disorder. Chronic inflammation is examined as a central mediator linking excessive adiposity to insulin resistance, type 2 diabetes, and cancer development, specifically detailing how adipose tissue dysfunction, altered adipokine profiles, and immune cell infiltration drive systemic pathogenesis. Emerging insights into the molecular mechanisms of tumor progression in a metabolically altered environment are highlighted, emphasizing the roles of hyperinsulinemia and dysregulated adipokines like leptin and adiponectin. In addition, the review explores innovative therapeutic strategies for obesity‐related cancer, including the use of metformin and therapies targeting insulin‐like growth factor 1 receptor and colony‐stimulating factor 1 receptor pathways. It also discusses the therapeutic promise of white adipose tissue browning through inductors such as menthol and capsinoids to enhance metabolic homeostasis. Furthermore, hormonal and neural dysregulation of appetite control are addressed. Novel pharmacological treatments targeting appetite, such as glucagon‐like peptide 1 and glucose‐dependent insulinotropic polypeptide receptor agonists, as well as neuromodulation techniques are discussed as promising avenues for personalized and effective interventions. This comprehensive understanding of obesity's complex nature is crucial for developing novel, integrated approaches to complement traditional diet and exercise strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Investigación en Biotecnología y Salud (IDiBE), Universidad Miguel Hernández de Elche (UMH), Elche, Spain.
- Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
- Department of Applied Biology-Nutrition, Instituto de Bioingeniería, Universidad Miguel Hernandez de Elche, Elche, Spain.
ORCID-Profile: Mariló Olivares-Vicente, María Herranz-López
Förderung
- Spanish Ministry of Economy and Competitiveness
- Generalitat Valenciana
- Spanish Ministry of Science, Innovation and Universities
- CIBEROBN
Zitieren
APA
Martínez-Godfrey, J., Pomares-Bri, I., de Juan-Maciá, P., Olivares-Vicente, M., Barrajón-Catalán, E., Micol, V., Roche, E., & Herranz-López, M. (2026). Innovations in Obesity Treatment: Beyond Adipose Tissue Dysfunction. Obesity Reviews, 27(12). https://doi.org/10.1111/obr.70164
Vancouver
Martínez-Godfrey J, Pomares-Bri I, de Juan-Maciá P, Olivares-Vicente M, Barrajón-Catalán E, Micol V, et al. Innovations in Obesity Treatment: Beyond Adipose Tissue Dysfunction. Obesity Reviews. 2026;27(12). doi:10.1111/obr.70164
BibTeX
@article{MartnezGodfrey2026,
author = {Martínez-Godfrey, Jesica and Pomares-Bri, Irene and de Juan-Maciá, Paula and Olivares-Vicente, Mariló and Barrajón-Catalán, Enrique and Micol, Vicente and Roche, Enrique and Herranz-López, María},
title = {Innovations in Obesity Treatment: Beyond Adipose Tissue Dysfunction},
journal = {Obesity Reviews},
year = {2026},
volume = {27},
number = {12},
doi = {10.1111/obr.70164}
}
EUVIMED